newsfilter
← Latest News
Business Wire·

NeoGenomics Announces Pricing of Offering of $275 Million Convertible Senior Notes

NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, announced today the pricing of its previously announced private offering of $275 million aggregate